Loading please wait...
Loading please wait...
AUANewsWorthy Webinar: Complexities and Challenges in cUTIs – an update for Urologists
Join distinguished clinicians and researchers in the field of urology, as they discuss the latest strategies in managing complicated urinary tract infections (cUTIs). This webinar will provide an in-depth look at the evolving role of Urologists in cUTI prevention and management, with a focus on practical considerations in clinical practice. The discussion will also cover practical factors influencing treatment decisions in cUTIs, with key insights into the challenges of treating multidrug-resistant organisms (MDROs), including ESBL Enterobacterales. Through expert analysis and real-world examples, this session aims to equip Urologists with the knowledge needed to optimize patient outcomes in the face of these complex infections. The webinar will conclude with a live Q&A, offering participants the opportunity to engage directly with the speakers.
Jason Pogue
Dr. Jason Pogue is a clinical professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and an Infectious Diseases Clinical Pharmacist at Michigan Medicine. Prior to this position he spent just over a decade at the Detroit Medical Center (DMC) as an Infectious Diseases Clinical Pharmacist at Sinai-Grace Hospital and as the co-chair of the Antimicrobial Stewardship Committee at the DMC. Dr. Pogue received a bachelor’s degree in chemistry from Gannon University, before obtaining his Doctor of Pharmacy degree from the University of Pittsburgh. He then completed a PGY-1 pharmacy residency at the University of Pittsburgh Medical Center followed by an infectious diseases PGY-2 residency at the University of Michigan Health Systems. His research interests focus on epidemiology and management of multi-drug resistant Gram-negative organisms and antimicrobial stewardship. Dr. Pogue is a recognized leader in Gram-negative resistance and antimicrobial stewardship as evidenced by his significant contribution of over 145 peer-reviewed articles, over 140 abstracts, multiple book chapters, and presentations at numerous national and international conferences. He currently serves as the co-lead investigator for the PRECEDENT network, a consortium of over 40 hospitals in the United States focused on performing real-world, comparative effectiveness syudies of novel antimicrobial agents for the treatment of resistant Gram-negative pathogens. Dr. Pogue is a past president of the Society of Infectious Diseases Pharmacists (SIDP) and currently serves as Chair of the Executive Committee of The United States Committee on Antimicrobial Susceptibility Testing (USCAST).
... Show MoreGSK Opening Slides
00:00:32